期刊
ONCOLOGY RESEARCH
卷 27, 期 7, 页码 849-858出版社
TECH SCIENCE PRESS
DOI: 10.3727/096504018X15447833065047
关键词
Triptolide (TPL); Cancer cells; Molecular signaling pathways; Antitumor effects
类别
资金
- National Natural Science Foundation of China [81703036, 81803035, 81572946]
- China Postdoctoral Science Foundation [2017M610510]
- Changsha Science and Technology Project [k1508024-31]
- Youth Fund of Xiangya Hospital [2017Q17]
- Postdoctoral Science Foundation of Central South University [185702]
Over the past decade, natural compounds have been proven to be effective against many human diseases, including cancers. Triptolide (TPL), a diterpenoid triepoxide from the Chinese herb Tripterygium wilfordii Hook F, has exhibited attractive cytotoxic activity on several cancer cells. An increasing number of studies have emphasized the antitumor effects of TPL on non-small cell lung cancer (NSCLC). Here we mainly focused on the key molecular signaling pathways that lead to the inhibitory effects of TPL on human NSCLC, such as mitogen-activated protein kinases (MAPKs) modulation, inhibition of NF-kappa B activation, suppression of miRNA expression, etc. In addition, the effect of TIG on immune response in cancer patients is summarized for improved immune modulation utilization. However, the clinical use of TPL is often limited by its severe toxicity and water insolubility. Future clinical trials and drug delivery strategies that will evaluate the security and validate the underlying tumor-killing properties of TPL in human NSCLC are also to be discussed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据